AMRN

#3389
Amarin Corp Plc
13.9500 USD
-0.07%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
13.4000
13.9900
年范围
13.4000
17.0000
日变化
-0.07%
每月变动
-3.46%
6个月变化
-10.35%
年变化
-10.35%
前一天收盘价
13.9600
开盘价
13.4000
最低价
13.4000
High
13.9900
交易量
49
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 290.2152 M
  • Employee 80
  • Founded 1989
  • CEO N/A
  • Website www.amarincorp.com
  • Headquarter United Kingdom
  • FIGI BBG000BPYG99
  • Industry 药品制造—常规
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-155.06
市销率
27.11

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

新闻